Leukine
Leukine ingredients
| Active ingredient | Strength |
|---|---|
| Sargramostim | 250 ug/mL |
What Leukine is used for
The FDA lists the approved uses on the official label (below). In the EU, sargramostim is approved as Imreplys for:
Imreplys is indicated for treatment of patients of all ages acutely exposed to myelosuppressive doses of radiation with Haematopoietic Sub-syndrome of Acute Radiation Syndrome (H-ARS). Imreplys should be used in accordance with official radiological/nuclear emergency recommendations.
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Leukine
- Generic name
- Sargramostim
- Made by
- Partner Therapeutics, Inc.
- Forms
- Injection, Powder, Lyophilized, For Solution
- Given
- Intravenous, Subcutaneous
- Drug class
- Leukocyte Growth Factor
- FDA approval
- Biologic licence (BLA) BLA103362
- On the US market since
- 2023
Official information
- Leukine prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Sargramostim)
In India
- Sargramostim: 2 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Leukine?
Leukine (Sargramostim) is a specialist medicine made by Partner Therapeutics, Inc., approved by the US FDA.
What are the ingredients of Leukine?
Leukine contains Sargramostim (250 ug/mL).
Is Leukine approved in Europe?
The same active substance is approved in the EU as Imreplys.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA